Goldman Sachs Knock-Out BAX/ DE000GG85YD4 /
8/2/2024 9:44:29 PM | Chg.-0.030 | Bid10:00:36 PM | Ask10:00:36 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.320EUR | -8.57% | - Bid Size: - |
- Ask Size: - |
Baxter International... | 32.2085 USD | 12/31/2078 | Call |
GlobeNewswire
6/26
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire
6/20
ProvisionAi COO Terri Bennett Robbins Named One of 20 Women Reshaping the Future of Logistics and th...
GlobeNewswire
6/20
E-fuels offer long-term solution to key energy transition transport sectors, but journey needs to st...
GlobeNewswire
6/14
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payme...
GlobeNewswire
6/12
2024 RealTrends + Tom Ferry The Thousand List Recognizes 44 eXp Realty Agents and Teams
GlobeNewswire
6/12
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
5/16
US November election results could decelerate energy transition, with $1 trillion in energy investme...
GlobeNewswire
5/15
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...